Drug Discovery Advancement Consultancy

Description

This University of Edinburgh requires highly specialised drug discovery and development consultancy including spinout and commercialisation support.

Key facts

Procedure

Award procedure without prior publication of a call for competition

Lots

1

Contact

Jade Millar

jmilla4@ed.ac.uk

+44 1316502759

Category

services

Awarded suppliers

• Future Bio Consulting Ltd · GB-FTS-187927 · UK

Ground given for limiting competition

The buyer’s own stated reason for awarding without open competition, as published. Their assertion, not a finding.

The Baillie Gifford Pandemic Sciences Hub intend to appoint Future Bio Consultancy to provide highly specialised strategic advisory services in drug discovery and development including associated spinout and commercialisation support. The University considers competition to be absent for technical reasons as per Public Contracts (Scotland) Regulations 2015-33 (1) (b) (ii)Technical Reasons: The consultant identified possesses unique scientific, medical, commercial skills and project-specific knowledge (including therapeutic innovation, AI integration, strategic collaborations, and resource mobilisation) that are all required collectively to enable the University to meet its project requirements.